Aarti Drugs Ltd: Trading Window Closed for ESOP Plan Approval

Aarti Drugs Ltd has announced the closure of its trading window from August 25, 2026, to August 29, 2026. This closure is in anticipation of a Board of Directors meeting scheduled for August 27, 2026. The primary agenda for this meeting is to consider and approve the 'Aarti Drugs Limited – Performance Stock Option Plan 2026', along with related matters. The company has cited SEBI (Prohibition of Insider Trading) Regulations, 2015, and its internal code of conduct as reasons for the trading window restriction. The information is also available on the company's website.